Glycoprotein Ibα inhibitor (CCP-224) prevents neutrophil-platelet aggregation in sickle cell disease

• Maritza A. Jimenez,
• Enrico M. Novelli,
• Gray D. Shaw,
• Prithu Sundd

Affiliations

Maritza A. Jimenez

Pittsburgh Heart, Lung, and Blood Vascular Medicine Institute, School of Medicine,; Department of Bioengineering, Swanson School of Engineering, and

Enrico M. Novelli

Pittsburgh Heart, Lung, and Blood Vascular Medicine Institute, School of Medicine,; Division of Hematology and Oncology, School of Medicine, University of Pittsburgh, Pittsburgh, PA;

Gray D. Shaw

Quell Pharma, Inc., Half Moon Bay, CA; and

Prithu Sundd

Pittsburgh Heart, Lung, and Blood Vascular Medicine Institute, School of Medicine,; Department of Bioengineering, Swanson School of Engineering, and; Division of Pulmonary, Allergy and Critical Care Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, PA; Prithu Sundd, University of Pittsburgh School of Medicine, Biomedical Science Tower E1255, 200 Lothrop St, Pittsburgh, PA 15261;